Integrated Hypertension and HIV Care Cascades in an HIV Treatment Program in Eastern Uganda: A Retrospective Cohort Study.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
15 08 2019
Historique:
pubmed: 3 5 2019
medline: 15 4 2020
entrez: 3 5 2019
Statut: ppublish

Résumé

Persons living with HIV (PLHIV) are at increased risk of cardiovascular disease. Integration of services for hypertension (HTN), the primary cardiovascular disease risk factor, into HIV care programs is recommended in Uganda, though, uptake has been limited. We sought to compare the care cascades for HTN and HIV within an HIV program in Eastern Uganda. We conducted a retrospective cohort study of all PLHIV enrolled in 3 HIV clinics between 2014 and 2017. We determined the proportion of patients in the following cascade steps over 12 months: Screened, Diagnosed, Initiated on treatment, Retained, Monitored, and Controlled. Cascades were analyzed using descriptive statistics and compared using χ and t tests. Of 1649 enrolled patients, 98.5% were initiated on HIV treatment, of whom 70.7% were retained in care, 100% had viral load monitoring, and 90.3% achieved control (viral suppression). Four hundred fifty-six (27.7%) participants were screened for HTN, of whom 46.9% were diagnosed, 88.1% were initiated on treatment, 57.3% were retained in care, 82.7% were monitored, and 24.3% achieved blood pressure control. There were no differences in any HIV cascade step between participants with HIV alone and those with both conditions. The HIV care cascade approached global targets, whereas the parallel HTN care cascade demonstrated notable quality gaps. Management of HTN within this cohort did not negatively impact HIV care. Our findings suggest that models of integration should focus on screening PLHIV for HTN and retention and control of those diagnosed to fully leverage the successes of HIV programs.

Sections du résumé

BACKGROUND
Persons living with HIV (PLHIV) are at increased risk of cardiovascular disease. Integration of services for hypertension (HTN), the primary cardiovascular disease risk factor, into HIV care programs is recommended in Uganda, though, uptake has been limited. We sought to compare the care cascades for HTN and HIV within an HIV program in Eastern Uganda.
METHODS
We conducted a retrospective cohort study of all PLHIV enrolled in 3 HIV clinics between 2014 and 2017. We determined the proportion of patients in the following cascade steps over 12 months: Screened, Diagnosed, Initiated on treatment, Retained, Monitored, and Controlled. Cascades were analyzed using descriptive statistics and compared using χ and t tests.
RESULTS
Of 1649 enrolled patients, 98.5% were initiated on HIV treatment, of whom 70.7% were retained in care, 100% had viral load monitoring, and 90.3% achieved control (viral suppression). Four hundred fifty-six (27.7%) participants were screened for HTN, of whom 46.9% were diagnosed, 88.1% were initiated on treatment, 57.3% were retained in care, 82.7% were monitored, and 24.3% achieved blood pressure control. There were no differences in any HIV cascade step between participants with HIV alone and those with both conditions.
CONCLUSIONS
The HIV care cascade approached global targets, whereas the parallel HTN care cascade demonstrated notable quality gaps. Management of HTN within this cohort did not negatively impact HIV care. Our findings suggest that models of integration should focus on screening PLHIV for HTN and retention and control of those diagnosed to fully leverage the successes of HIV programs.

Identifiants

pubmed: 31045649
doi: 10.1097/QAI.0000000000002067
pmc: PMC6625912
mid: NIHMS1526881
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

552-561

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010540
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Am J Med. 2007 Aug;120(8):713-9
pubmed: 17679131
PLoS Med. 2007 Oct 16;4(10):e298
pubmed: 17941716
Bull World Health Organ. 2011 Jun 1;89(6):412-21
pubmed: 21673857
PLoS One. 2012;7(8):e43400
pubmed: 22916256
Lancet Infect Dis. 2013 May;13(5):436-48
pubmed: 23531392
J Hypertens. 2013 Jul;31(7):1372-8; discussion 1378
pubmed: 23615323
Lancet Infect Dis. 2014 Jan;14(1):40-49
pubmed: 24076277
J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26
pubmed: 24341872
Pan Afr Med J. 2013 Nov 06;16:84
pubmed: 24711874
BMC Infect Dis. 2014 May 22;14:284
pubmed: 24886474
BMC Res Notes. 2014 Oct 21;7:743
pubmed: 25335783
Trop Med Int Health. 2015 Mar;20(3):391-6
pubmed: 25430847
PLoS One. 2015 Sep 25;10(9):e0138991
pubmed: 26406462
Clin Infect Dis. 2016 Jul 15;63(2):205-13
pubmed: 27143668
PLoS One. 2016 May 27;11(5):e0156309
pubmed: 27232186
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
BMC Public Health. 2016 Sep 21;16(1):1002
pubmed: 27655406
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
PLoS Med. 2016 Oct 25;13(10):e1002149
pubmed: 27780217
BMC Res Notes. 2016 Nov 17;9(1):487
pubmed: 27855717
Cardiol Clin. 2017 Feb;35(1):99-115
pubmed: 27886793
J Int AIDS Soc. 2017 Jun 05;20(1):21590
pubmed: 28605171
AIDS Care. 2018 Jan;30(1):103-115
pubmed: 28679283
Pan Afr Med J. 2017 May 15;27:40
pubmed: 28761616
Curr Opin HIV AIDS. 2017 Nov;12(6):513-522
pubmed: 28787286
Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11):
pubmed: 29133472
BMC Public Health. 2017 Dec 12;17(1):947
pubmed: 29233114
Hypertension. 2018 Apr;71(4):577-584
pubmed: 29378852
PLoS One. 2018 Feb 8;13(2):e0192332
pubmed: 29420640
J Int AIDS Soc. 2018 Feb;21(2):
pubmed: 29479867
AIDS. 2018 Jul 1;32 Suppl 1:S1-S3
pubmed: 29952785
AIDS. 2018 Jul 1;32 Suppl 1:S5-S20
pubmed: 29952786
AIDS. 2018 Jul 1;32 Suppl 1:S33-S42
pubmed: 29952788
AIDS. 2018 Jul 1;32 Suppl 1:S43-S46
pubmed: 29952789
AIDS. 2018 Jul 1;32 Suppl 1:S47-S54
pubmed: 29952790
Lancet. 2018 Sep 8;392(10150):819-820
pubmed: 30215377

Auteurs

Martin Muddu (M)

Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Uganda Initiative for Integrated Management of Non-Communicable Diseases (UINCD), Kampala, Uganda.

Andrew K Tusubira (AK)

Uganda Initiative for Integrated Management of Non-Communicable Diseases (UINCD), Kampala, Uganda.

Srish K Sharma (SK)

Wake Forest School of Medicine, Winston-Salem, NC.

Ann R Akiteng (AR)

Uganda Initiative for Integrated Management of Non-Communicable Diseases (UINCD), Kampala, Uganda.

Isaac Ssinabulya (I)

Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Uganda Initiative for Integrated Management of Non-Communicable Diseases (UINCD), Kampala, Uganda.
Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.

Jeremy I Schwartz (JI)

Uganda Initiative for Integrated Management of Non-Communicable Diseases (UINCD), Kampala, Uganda.
Section of General Internal Medicine, Yale School of Medicine, CT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH